{"disease":{"id":"ascites","name":"Ascites","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":3,"pipeline_drug_count":0,"trial_count":2},"drugs":{"marketed":[{"drug_id":"potassium-bicarbonate","indication_name":"Prevention of Potassium Depletion - Hepatic Cirrhosis with Ascites","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"POTASSIUM BICARBONATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":14,"revenue":null,"mechanism":null},{"drug_id":"ethacrynic-acid","indication_name":"Ascites Due to Malignancy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Edecrin","generic_name":"ETHACRYNIC ACID","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Glutathione S-transferase P","drug_class":"Loop Diuretic [EPC]","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"albumin-human","indication_name":"Ascites","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ALBUMIN HUMAN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":45,"revenue":null,"mechanism":"Human Albumin 25% contributes to plasma colloid oncotic pressure and transports various substances, stabilizing blood volume."},{"drug_id":"spironolacton","indication_name":"Ascites","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Spironolacton","company_name":"ACS Biomarker","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Multidrug and toxin extrusion protein 1, Nuclear receptor subfamily 1 group I member 2","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"spironolactone","indication_name":"Ascites","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aldactone","generic_name":"spironolactone","company_name":"Generic (originally Searle/Pfizer)","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Multidrug and toxin extrusion protein 1, Nuclear receptor subfamily 1 group I member 2","drug_class":"Aldosterone Antagonist [EPC]","quality_score":56,"revenue":null,"mechanism":"Potassium-sparing diuretic and mineralocorticoid receptor antagonist that blocks aldosterone, reducing fluid retention and lowering blood pressure."},{"drug_id":"spirolactone","indication_name":"Ascites","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"spirolactone","company_name":"Second Xiangya Hospital of Central South University","drug_phase":"phase_1","molecular_target":"Cytochrome P450 2C19, Multidrug and toxin extrusion protein 1, Nuclear receptor subfamily 1 group I member 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":6,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03267615","title":"VICIS - Vienna Cirrhosis Study","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT04767945","title":"Cirrhosis Registry of Hospitalized Patients","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica","has_results":false},{"nct_id":"NCT06995846","title":"Application of Bacterial DNA Quantitative Detection in Diagnosis of SBP in Cirrhosis: A Multi Center Diagnostic Experiment","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":700,"lead_sponsor_name":"Beijing YouAn Hospital","has_results":false},{"nct_id":"NCT06196723","title":"Transjugular Intrahepatic Portosystemic Shunts Improve Survival in Patients With Cirrhosis and Recurrent Ascites","phase":"","overall_status":"COMPLETED","enrollment_count":462,"lead_sponsor_name":"Tang-Du Hospital","has_results":false},{"nct_id":"NCT06911554","title":"A Study of Recombinant Human Albumin Injection to Treat Hypoalbuminemia in Cirrhotic Patients With Ascites","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":416,"lead_sponsor_name":"Tonghua Anrate Biopharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT03451292","title":"Effects of Long-Term Administration of Human Albumin in Participants With Decompensated Cirrhosis and Ascites","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":410,"lead_sponsor_name":"Grifols Therapeutics LLC","has_results":true},{"nct_id":"NCT04326946","title":"International Alfapump Cohort Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Sequana Medical N.V.","has_results":false},{"nct_id":"NCT06553456","title":"Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":390,"lead_sponsor_name":"Protgen Ltd","has_results":false},{"nct_id":"NCT06432296","title":"Treatment of Malignant Ascites Caused by Advanced Epithelial Solid Tumors With M701 Bispecific Antibody","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":312,"lead_sponsor_name":"Wuhan YZY Biopharma Co., Ltd.","has_results":false},{"nct_id":"NCT04125654","title":"Metagenomic Next-Generation Sequencing for Diagnosis of Ascites Infection in End-stage Liver Diseases","phase":"NA","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT04835480","title":"A Phase II Study of OsrHSA in Patients With Decompensated Cirrhotic Ascites","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"Healthgen Biotechnology Corp.","has_results":false},{"nct_id":"NCT07521332","title":"Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"Asian Institute Of Medical Sciences","has_results":false},{"nct_id":"NCT03327688","title":"Point-of-care Ultrasound in Finland","phase":"NA","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"Ossi Hannula","has_results":false},{"nct_id":"NCT01059396","title":"Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":201,"lead_sponsor_name":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","has_results":false},{"nct_id":"NCT02649335","title":"To Study the Effect of Nonselective Beta Blockers in Advanced Stage Liver Disease With Ascites","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":190,"lead_sponsor_name":"Post Graduate Institute of Medical Education and Research, Chandigarh","has_results":false},{"nct_id":"NCT06436807","title":"PMCF Study of the CE-marked Drainova® ArgentiC Catheter","phase":"","overall_status":"COMPLETED","enrollment_count":169,"lead_sponsor_name":"ewimed GmbH","has_results":false},{"nct_id":"NCT06669806","title":"Effectiveness and Safety of TIPS Stent Graft in the Treatment of Cirrhosis and Complications of Portal Hypertension","phase":"NA","overall_status":"RECRUITING","enrollment_count":166,"lead_sponsor_name":"C. R. Bard","has_results":false},{"nct_id":"NCT03069131","title":"Two Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With Ascites","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"Centre Hospitalier Universitaire de Besancon","has_results":false},{"nct_id":"NCT03459378","title":"Outcome After TIPS","phase":"","overall_status":"COMPLETED","enrollment_count":158,"lead_sponsor_name":"Medical University of Graz","has_results":false},{"nct_id":"NCT05511766","title":"Allopurinol Versus Atorvastatin to Prevent Complications of Liver Cirrhosis","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Tanta University","has_results":false},{"nct_id":"NCT00825877","title":"Long-term Follow-up of HALT-C Sustained Virological Responders","phase":"","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT04208776","title":"Efficacy of Combination of Midodrine With Propranolol in Preventing First Bleed in Decompensated Cirrhotics With Severe Ascites.","phase":"NA","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"Institute of Liver and Biliary Sciences, India","has_results":false},{"nct_id":"NCT04533854","title":"Investigating Signal Change in Malignant and Non-malignant Pleural Effusions and asCitic Fluid Using fTiR Analysis","phase":"","overall_status":"COMPLETED","enrollment_count":137,"lead_sponsor_name":"Portsmouth Hospitals NHS Trust","has_results":false},{"nct_id":"NCT05278013","title":"Utility of 2- Octyl Cyanoacrylate (2-OCA)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":134,"lead_sponsor_name":"Methodist Health System","has_results":false},{"nct_id":"NCT06576934","title":"Early TIPS in Patients With Liver Cirrhosis and Ascites","phase":"NA","overall_status":"RECRUITING","enrollment_count":134,"lead_sponsor_name":"University Hospital Freiburg","has_results":false},{"nct_id":"NCT07196553","title":"Ultrasound and Ascites","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":125,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT05569798","title":"The INSIGHT Feasibility Study Ultrasound in the Intensive Care Unit: A Randomised Controlled Feasibility Trial","phase":"NA","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"King's College Hospital NHS Trust","has_results":false},{"nct_id":"NCT06266091","title":"Treat Malignant Ascites Caused by Gastrointestinal or Ovarian Cancer With M701 Bispecific Antibody","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":115,"lead_sponsor_name":"Wuhan YZY Biopharma Co., Ltd.","has_results":false},{"nct_id":"NCT02122185","title":"Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":111,"lead_sponsor_name":"University of Chicago","has_results":true},{"nct_id":"NCT03973866","title":"Alfapump® System in the Treatment of Refractory or Recurrent Ascites (POSEIDON Study)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":110,"lead_sponsor_name":"Sequana Medical N.V.","has_results":false},{"nct_id":"NCT07113808","title":"Pediatric Intravenous Contrast-Enhanced Ultrasound(CEUS) in China","phase":"","overall_status":"RECRUITING","enrollment_count":108,"lead_sponsor_name":"The Children's Hospital of Zhejiang University School of Medicine","has_results":false},{"nct_id":"NCT05621005","title":"Rifaximin Prophylaxis for Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome in Cirrhotic Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":104,"lead_sponsor_name":"Samar Atef Sebaweh Mohammed","has_results":false},{"nct_id":"NCT03191851","title":"Evaluation of 'Melody' Paracentesis Device for Ascites Therapy","phase":"NA","overall_status":"COMPLETED","enrollment_count":101,"lead_sponsor_name":"University of Nottingham","has_results":false},{"nct_id":"NCT05793983","title":"S100A8/A9 and Innate Immunity in Liver Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"St George's, University of London","has_results":false},{"nct_id":"NCT03550560","title":"EUS-Guided Drainage of Refractory Malignant Ascites","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Hospital Universitario Virgen Macarena","has_results":false},{"nct_id":"NCT03318601","title":"Evaluation of Copeptin in Patients With Cirrhosis and Ascites","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Centre Hospitalier Universitaire de Besancon","has_results":false},{"nct_id":"NCT05867602","title":"High Dose Albumin in Refractory Ascites","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Baylor College of Medicine","has_results":false},{"nct_id":"NCT05858853","title":"Phase II/III of Recombinant Human Serum Albumin","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"Protgen Ltd","has_results":false},{"nct_id":"NCT06411743","title":"Phase II/III of Recombinant Human Albumin Injection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"The First Hospital of Jilin University","has_results":false},{"nct_id":"NCT06658080","title":"Drug Sensitivity of Hydrothorax and Ascite Organoids from Breast Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT06827756","title":"Comparative Study of Secondary Prophylaxis for SBP","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Tanta University","has_results":false},{"nct_id":"NCT03506893","title":"Medical-economic Evaluation of the Care of Refractory Ascites by Implantation of Alfapump® Device in Cirrhotic Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"University Hospital, Grenoble","has_results":false},{"nct_id":"NCT04785755","title":"Effects of Adding Hypertonic Saline Solutions and/or Etilefrine to Standard Diuretics Therapy in Hepatic Ascites","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Hala Abd EL-Tawab Ibrahim Radwan","has_results":false},{"nct_id":"NCT04221672","title":"The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":86,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT06856655","title":"Achieving Portal Access With Scorpion Post-Approval Study 2","phase":"","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"Argon Medical Devices","has_results":false},{"nct_id":"NCT04650295","title":"Non-Pharmaceutical Intervention for Cirrhotic Cramps Reduction: The NICCles Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"University of Michigan","has_results":false},{"nct_id":"NCT05700708","title":"Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Refractory Ascites","phase":"","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Post Graduate Institute of Medical Education and Research, Chandigarh","has_results":false},{"nct_id":"NCT04641364","title":"Safety and Tolerance Study of Recombinant Human Albumin Injection in Healthy Subjects.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"The First Hospital of Jilin University","has_results":false},{"nct_id":"NCT05578573","title":"Comparison Between Conventional Angiocatheter Versus New Anchoring Device (KARAHOC) Used for Paracentesis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Sang Gyune Kim","has_results":false},{"nct_id":"NCT05434286","title":"Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Hepatorenal Syndrome-Acute Kidney Injury","phase":"","overall_status":"UNKNOWN","enrollment_count":75,"lead_sponsor_name":"Post Graduate Institute of Medical Education and Research, Chandigarh","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}